Email ID
Password
Scrip   
Interview: Rexbio sets sights on novel approach to pancreatic cancer
08 February 2010
Ian Haydock

The South Korean bioventure Rexbio is looking to develop a novel approach to the treatment and diagnosis of one of the most deadly forms of cancer by targeting a gene found to be closely linked to the malignancy.

The small, privately held company is focusing on pancreatic adenocarcinoma up-regulated...



Please Login to read the full article.
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36